Ila Datar
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 8
- Peptidase Inhibition and Analysis 2
-
- Melanoma and MAPK Pathways 3
- Co-authors
- Kurt A. Schalper (11 shared papers)Roy S. Herbst (10 shared papers)Vamsidhar Velcheti (4 shared papers)Lieping Chen (3 shared papers)Konstantinos Syrigos (2 shared papers)Nikita Mani (3 shared papers)Franz Villarroel‐Espíndola (5 shared papers)Miguel F. Sanmamed (4 shared papers)
- Journals
- PLoS ONE (3 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesKuwaitChina
In The Last Decade
Ila Datar
16 papers receiving 448 citations
Peers
Comparison fields: 5 of 51
- Oncology 252
- Immunology 155
- Developmental Neuroscience 14
- Pathology and Forensic Medicine 46
- Cancer Research 37
Countries citing papers authored by Ila Datar
This map shows the geographic impact of Ila Datar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ila Datar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ila Datar more than expected).
Fields of papers citing papers by Ila Datar
This network shows the impact of papers produced by Ila Datar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ila Datar. The network helps show where Ila Datar may publish in the future.
Co-authors
The 25 scholars most cited alongside Ila Datar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 171 | |
| 2 | 2022 | 93 | |
| 3 | 2015 | 46 | |
| 4 | 2013 | 33 | |
| 5 | 2015 | 28 | |
| 6 | 2021 | 27 | |
| 7 | 2014 | 15 | |
| 8 | 2022 | 8 | |
| 9 | 2012 | 8 | |
| 10 | 2019 | 6 | |
| 11 | 2017 | 6 | |
| 12 | 2017 | 4 | |
| 13 | 2017 | 2 | |
| 14 | 2017 | 2 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2017 | 0 |
About Ila Datar
Ila Datar is a scholar working on Oncology, Molecular Biology, Immunology, Pathology and Forensic Medicine and Biotechnology, having authored 17 papers that have together received 451 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Mechanisms and Therapy (3 papers), Immunotherapy and Immune Responses (3 papers), Melanoma and MAPK Pathways (3 papers), Cancer Research and Treatments (3 papers), Immune cells in cancer (3 papers), Ferroptosis and cancer prognosis (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (252 citations), Immunology (155 citations), Developmental Neuroscience (14 citations), Pathology and Forensic Medicine (46 citations) and Cancer Research (37 citations). Ila Datar has collaborated with scholars based in United States, Kuwait and China. Frequent co-authors include Kurt A. Schalper, Roy S. Herbst, Vamsidhar Velcheti, Lieping Chen, Konstantinos Syrigos, Nikita Mani, Franz Villarroel‐Espíndola, Miguel F. Sanmamed, Maria Toki and Kam C. Yeung. Their work appears in journals such as PLoS ONE, Cancer Research, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.